{"doc_desc":{"title":"Cancerologie : base de donn\u00e9es de patients en vie r\u00e9elle en oncologie et en onco-h\u00e9matologie","idno":"FRESH-PEF73432-fr","producers":[{"name":"C\u00e9cile PACHECO","affiliation":"KANTAR FRANCE HOLDINGS"}]},"study_desc":{"title_statement":{"idno":"FRESH-PEF73432-fr","IDno":{"metadata_no":[{"agency":"PEF","code":"73432"},{"agency":"FReSH","code":"FRESH-PEF73432"}]},"title":"Cancerologie : base de donn\u00e9es de patients en vie r\u00e9elle en oncologie et en onco-h\u00e9matologie","alternate_title":"Cancerology"},"study_authorization":{"agency":[{"name":"CNIL"}]},"authoring_entity":[{"type":"investigator","name":"Genevi\u00e8ve;BONNELYE","PILabo":"Kantar Health division \/ Health division","affiliationName":"KANTAR FRANCE HOLDINGS","extlink":[{"title":"","uri":"","role":"pi id"},{"title":"","uri":"","role":"pi id"},{"title":"SIREN","uri":"853207918","role":"organisation id"},{"title":"","uri":"","role":"labo id"}],"email":"genevieve.bonnelye@kantar.com","isContact":"Oui"},{"type":"investigator","name":"H\u00e9l\u00e8ne;CHALUBERT","PILabo":"Kantar Health division \/ Health division","affiliationName":"KANTAR FRANCE HOLDINGS","extlink":[{"title":"","uri":"","role":"pi id"},{"title":"","uri":"","role":"pi id"},{"title":"SIREN","uri":"853207918","role":"organisation id"},{"title":"","uri":"","role":"labo id"}],"email":"Helene.Chalubert@kantar.com","isContact":"Oui"},{"type":"investigator","name":"C\u00e9cile;PACHECO","PILabo":"Kantar Health division \/ Health division","affiliationName":"KANTAR FRANCE HOLDINGS","extlink":[{"title":"","uri":"","role":"pi id"},{"title":"","uri":"","role":"pi id"},{"title":"SIREN","uri":"853207918","role":"organisation id"},{"title":"","uri":"","role":"labo id"}],"email":"Cecile.PACHECO@kantar.com","isContact":"Oui"}],"oth_id":[{"name":""}],"production_statement":{"prod_place":"Portail Epid\u00e9miologie France (PEF)","producers":[{"name":"KANTAR FRANCE HOLDINGS","extlink":[{"title":"ROR","uri":"https:\/\/ror.org\/04ergcq69","role":"sponsor id"},{"title":"SIREN","uri":"853207918","role":"sponsor id"}],"role":"sponsor"}],"funding_agencies":[{"name":""}]},"distribution_statement":{"contact":[{"name":"Genevi\u00e8ve;BONNELYE","email":"genevieve.bonnelye@kantar.com","type":"contact","affiliationName":"KANTAR FRANCE HOLDINGS","contactPointLabo":"","extlink":[{"uri":"https:\/\/ror.org\/04ergcq69","role":"organisation id","title":"ROR"},{"uri":"853207918","role":"organisation id","title":"SIREN"}]},{"name":"H\u00e9l\u00e8ne;CHALUBERT","email":"Helene.Chalubert@kantar.com","type":"contact","affiliationName":"KANTAR FRANCE HOLDINGS","contactPointLabo":"","extlink":[{"uri":"https:\/\/ror.org\/04ergcq69","role":"organisation id","title":"ROR"},{"uri":"853207918","role":"organisation id","title":"SIREN"}]},{"name":"C\u00e9cile;PACHECO","email":"Cecile.PACHECO@kantar.com","type":"contact","affiliationName":"KANTAR FRANCE HOLDINGS","contactPointLabo":"","extlink":[{"uri":"https:\/\/ror.org\/04ergcq69","role":"organisation id","title":"ROR"},{"uri":"853207918","role":"organisation id","title":"SIREN"}]}]},"study_info":{"keywords":[{"keyword":"Oncologie"},{"keyword":"tumeur solide"},{"keyword":"tumeur non solide"},{"keyword":"tumeur liquide"},{"keyword":"caract\u00e9ristiques des patients"},{"keyword":"s\u00e9quen\u00e7age du traitement"},{"keyword":"th\u00e9rapie cibl\u00e9e"},{"keyword":"h\u00e9matologie"},{"keyword":"profil clinique"},{"keyword":"biomarqueur"},{"keyword":"chimioth\u00e9rapie"},{"keyword":"s\u00e9curit\u00e9"},{"keyword":"comorbidit\u00e9s"}],"topics":[{"topic":"Oncologie","vocab":"health theme","extLink":[{"title":"ESV","uri":"http:\/\/data.europa.eu\/8mn\/euroscivoc\/5784b7f1-c7ce-49d9-9f38-aebcda0ff41d"},{"title":"MeSH","uri":"http:\/\/id.nlm.nih.gov\/mesh\/D008495"}]},{"topic":"H\u00e9matologie","vocab":"health theme","extLink":[{"title":"ESV","uri":"http:\/\/data.europa.eu\/8mn\/euroscivoc\/9239f328-78c9-40a5-a0b9-8e66fd9b6245"},{"title":"MeSH","uri":"http:\/\/id.nlm.nih.gov\/mesh\/D006402"}]},{"topic":"Tumeurs","vocab":"cim-11","extLink":[{"uri":"http:\/\/id.who.int\/icd\/entity\/1630407678","title":"CIM-11"}]},{"topic":"D\u00e9terminants comportementaux : Addictions","vocab":"health determinant"},{"topic":"D\u00e9terminants socio-d\u00e9mographiques et \u00e9conomiques","vocab":"health determinant"},{"topic":"D\u00e9terminants biologiques : Pr\u00e9dispositions g\u00e9n\u00e9tiques","vocab":"health determinant"},{"topic":"D\u00e9terminants environnementaux : Autres","vocab":"health determinant"},{"topic":"D\u00e9terminants comportementaux","vocab":"health determinant"},{"topic":"D\u00e9terminants comportementaux : Alimentation","vocab":"health determinant"},{"topic":"D\u00e9terminants environnementaux","vocab":"health determinant"},{"topic":"D\u00e9terminants li\u00e9s au syst\u00e8me de sant\u00e9 : Consommation des soins","vocab":"health determinant"},{"topic":"Syst\u00e8mes de soins et acc\u00e8s aux soins","vocab":"health determinant"},{"topic":"D\u00e9terminants biologiques","vocab":"health determinant"},{"topic":"D\u00e9terminants li\u00e9s au syst\u00e8me de sant\u00e9","vocab":"health determinant"}],"purpose":"D\u00e9terminer l'\u00e9pid\u00e9miologie, les caract\u00e9ristiques des patients et des tumeurs, les biomarqueurs, les sch\u00e9mas de traitement d\u00e9taill\u00e9s, la s\u00e9curit\u00e9 et les r\u00e9sultats cliniques pour plus de 25 tumeurs solides et non solides en France, en Allemagne, en Italie, en Espagne et au Royaume-Uni.","abstract":"","coll_dates":[{"start":"1993-01-01","end":"2020-01-01"}],"nation":[{"name":"France","abbreviation":"fr","extLink":{"vocab":"ISO","vocabURI":"fr"}},{"name":"Allemagne","abbreviation":"de","extLink":{"vocab":"ISO","vocabURI":"de"}},{"name":"Italie","abbreviation":"it","extLink":{"vocab":"ISO","vocabURI":"it"}},{"name":"Espagne","abbreviation":"es","extLink":{"vocab":"ISO","vocabURI":"es"}},{"name":"Royaume-Uni","abbreviation":"gb","extLink":{"vocab":"ISO","vocabURI":"gb"}}],"geog_coverage":"","analysis_unit":"Individus","universe":"{\n    \"level_sex_clusion_I\": [\n        {\n            \"value\": \"Masculin\",\n            \"concept\": {\n                \"vocab\": \"MeSH\",\n                \"vocabURI\": \"http:\\\/\\\/id.nlm.nih.gov\\\/mesh\\\/D008297\"\n            }\n        },\n        {\n            \"value\": \"F\u00e9minin\",\n            \"concept\": {\n                \"vocab\": \"MeSH\",\n                \"vocabURI\": \"http:\\\/\\\/id.nlm.nih.gov\\\/mesh\\\/D005260\"\n            }\n        }\n    ],\n    \"level_age_clusion_I\": [\n        {\n            \"value\": \"Adulte (19 \u00e0 24 ans)\",\n            \"concept\": {\n                \"vocab\": \"MeSH\",\n                \"vocabURI\": \"http:\\\/\\\/id.nlm.nih.gov\\\/mesh\\\/D055815\"\n            }\n        },\n        {\n            \"value\": \"Adulte (25 \u00e0 44 ans)\",\n            \"concept\": {\n                \"vocab\": \"MeSH\",\n                \"vocabURI\": \"http:\\\/\\\/id.nlm.nih.gov\\\/mesh\\\/D000328\"\n            }\n        },\n        {\n            \"value\": \"Adulte (45 \u00e0 64 ans)\",\n            \"concept\": {\n                \"vocab\": \"MeSH\",\n                \"vocabURI\": \"http:\\\/\\\/id.nlm.nih.gov\\\/mesh\\\/D008875\"\n            }\n        },\n        {\n            \"value\": \"Personne \u00e2g\u00e9e (65 \u00e0 79 ans)\",\n            \"concept\": {\n                \"vocab\": \"MeSH\",\n                \"vocabURI\": \"http:\\\/\\\/id.nlm.nih.gov\\\/mesh\\\/D000368\"\n            }\n        },\n        {\n            \"value\": \"Grand \u00e2ge (80 ans et plus)\",\n            \"concept\": {\n                \"vocab\": \"MeSH\",\n                \"vocabURI\": \"http:\\\/\\\/id.nlm.nih.gov\\\/mesh\\\/D000369\"\n            }\n        }\n    ],\n    \"level_type_clusion_I\": \"Patients\",\n    \"level_type_clusion_other\": \"\",\n    \"clusion_I\": \"Patients recevant actuellement un traitement m\u00e9dicamenteux anti-tumoral actif\",\n    \"clusion_E\": \"\"\n}","data_kind":"['Donn\u00e9es cliniques','Donn\u00e9es rapport\u00e9es par le participant de l'\u00e9tude','Donn\u00e9es biologiques']","quality_statement":{"standards":[{"name":"","committee":"","governance":""}],"other_quality_statement":"['ISO 20252']"}},"study_development":{"development_activity":[{"activity_type":"primary evaluation","activity_description":"Ev\u00e9nements de sant\u00e9\/morbidit\u00e9\r\nAutres"}]},"method":{"data_collection":{"time_method":"Etude transversale r\u00e9p\u00e9t\u00e9e","frequency":"","sampling_procedure":"['{\"concept\":{\"vocabURI\":\"Probability.Cluster\",\"vocab\":\"CESSDA\"},\"value\":\"Probabiliste : grappe\"}']","sample_frame":{"frame_unit":{"unit_type":"['Via les professionnels d'exercice lib\u00e9ral Via des structures (services ou \u00e9tablissements de sant\u00e9, \u00e9coles, entreprises\u2026)']"}},"coll_mode":["{\"concept\":{\"vocabURI\":\"SelfAdministeredQuestionnaire\",\"vocab\":\"CESSDA\"},\"value\":\"Questionnaire auto-administr\u00e9\"}"],"research_instrument":"Acc\u00e8s restreint sur projet sp\u00e9cifique","sources":[],"target_sample_size":"[1000-10000[ individus","response_rate":"Veuillez contacter directement la division Kantar Health"},"method_notes":"Etude observationnelle","study_class":"Inconnu","notes":[{"subject":"research type","values":["Etude observationnelle"]}]},"data_access":{"dataset_availability":{"access_place":"","complete":"","status":"{\"value\":\"Acc\u00e8s aux seules m\u00e9tadonn\u00e9es\",\"extLink\":[{\"title\":\"COAR\",\"uri\":\"http:\/\/purl.org\/coar\/access_right\/c_14cb\"}]}"},"dataset_use":{"restrictions":"","conditions":"Veuillez contacter directement la division Kantar Health","conf_dec":[{"txt":""}],"spec_perm":[{"txt":"","required":""}],"contact":[{"name":""}],"deposit_req":"","cit_req":""},"notes":""}},"additional":{"IsImport":true,"versionLang":"fr","originLang":"fr","autoTranslation":false,"status":"imported","creationDate":"08-09-2020","lastUpdatedAuto":null,"lastUpdatedManual":"07-07-2025","isContributorPI":"Non","contributorName":"C\u00e9cile PACHECO","contributorAffiliation":"KANTAR FRANCE HOLDINGS","addTeamMember":"","obtainedAuthorization":{"otherAuthorizingAgency":[""]},"relatedDocument":[{"type":"","title":"","link":"http:\/\/epidemiologie-france.aviesan.fr\/E. Manna, K. Kikuchi , H. Chalubert , I. Amri, P. Medina. BRAF mutation testing and results among French patients with solid tumours. Poster to be presented at ESMO 2020."}],"regulatoryRequirements":{"conformityDeclaration":""},"fundingAgent":{"fundingAgentType":[],"otherFundingAgentType":[]},"sponsor":{"sponsorType":["Industrie"],"otherSponsorType":[""]},"governance":{"committee":"Non"},"collaborations":{"networkConsortium":""},"theme":{"complementaryInformation":"","RareDiseases":"Oui"},"activeFollowUp":{"isActiveFollowUp":"Non","followUpModeOther":""},"interventionalStudy":{"researchPurpose":[],"trialPhase":[],"interventionalStudyModel":"","isClinicalTrial":"","otherResearchPurpose":""},"isInclusionGroups":"","allocation":{"allocationMode":"","allocationUnit":""},"masking":{"maskingType":"","blindedMaskingDetails":[]},"arms":[],"intervention":[],"inclusionGroups":[],"collectionProcess":{"collectionModeDetails":"Questionnaire auto-administr\u00e9 en face \u00e0 face et formulaires de rapport de cas","collectionModeOther":""},"dataCollection":{"inclusionStrategyOther":"","samplingModeOther":"","recruitmentSourceOther":"","otherDocumentation":""},"dataCollectionIntegration":{"isDataIntegration":"Non"},"geographicalCoverage":{"geoDetail":"France, Allemagne, Italie, Espagne, Royaume-Uni"},"dataTypes":{"clinicalDataDetails":"Caract\u00e9ristiques des patients, profil clinique, caract\u00e9ristiques des tumeurs, s\u00e9curit\u00e9, r\u00e9sultats cliniques","biologicalDataDetails":"Biomarkers","isDataInBiobank":"Non","biobankContent":[],"biobankContentOther":"","dataTypeOther":""},"variableDictionnary":{"variableDictionnaryAvailable":"","variableDictionnaryLink":""},"dataQuality":{"otherDocumentation":""},"mockSample":{"mockSampleAvailable":"","mockSampleLocation":""},"thirdPartySource":{"otherSourceType":[]},"isHealthTheme":"Oui","fileDscr":{"fileTxt":{"fileCitation":{"titlStmt":{"IDno":[]}}}}},"schematype":"survey"}